Cobra Biologics

Cobra Biologics is a company that provides biologics and pharmaceuticals for pre-clinical, clinical, and commercial supply. It focuses on DNA, viral vector, and microbiota products covering drug development and commercialization processes.

Employee Rating

2.7More
TypeSubsidiary
Parent CompanyCognate BioServices
HQKeele, GB
Founded1992
Websitecobrabio.com
Cybersecurity ratingBMore
Cobra Biologics was founded in 1992 and is headquartered in Keele, GB

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Cobra Biologics

Daniel Smith

Daniel Smith

Chief Scientific Officer
Lee Warren

Lee Warren

Finance Director
Mike Austin

Mike Austin

Vice President Operations
Philip Ridley-Smith

Philip Ridley-Smith

Sales and Marketing Director
Sheena Pumford Cipd

Sheena Pumford Cipd

HR Director
Tony Bradshaw

Tony Bradshaw

Director of Talent
Show more

Cobra Biologics Office Locations

Cobra Biologics has offices in Keele and Matfors
Keele, GB (HQ)
Science Park University of Keele
Matfors, SE
Storjordenvägen 2
Show all (2)

Cobra Biologics Financials and Metrics

Summary Metrics

Founding Date

1992

Total Funding

$7 m

Investors

In total, Cobra Biologics had raised $7 m. Cobra Biologics is a subsidiary of Cognate BioServices

Cobra Biologics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Cobra Biologics Online and Social Media Presence

Embed Graph

Cobra Biologics News and Updates

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

KEELE, United Kingdom, June 16, 2020 /PRNewswire/ -- Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. ("AstraZeneca") to provide GMP...

Cobra Biologics Blogs

Albumedix extends research collaboration with Cobra Biologics

Albumedix ('Albumedix') an emerging leader in the enablement of advanced therapies and recognized global leader in recombinant human albumin (rHA) has today announced an extension to its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Char…

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million, subject to customary closing adjustments.

Charles River to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development

Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution from Discovery through CGMP Manufacturing WILMINGTON, Mass.…

INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development

Thomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex Brownfield, Business Development Director at Cobra.

Cobra Biologics Team Celebrates Double Award Win

This month, the Cobra team is delighted to have received a pair of shiny new industry awards, recognising the company's contribution to the fight against COVID-19, and in providing an alternative route to the workplace through advanced therapies apprenticeships. 

Cobra Biologics Shortlisted for Two Bionow Awards 2021

Showcasing the best of this world class sector, the prestigious Bionow Awards remains a highlight of the life sciences calendar. For 2021, a digital ceremony will bring the sector together to celebrate excellence and provides an opportunity to dust off your black tie or evening dress and…
Show more

Cobra Biologics Frequently Asked Questions

  • When was Cobra Biologics founded?

    Cobra Biologics was founded in 1992.

  • Who are Cobra Biologics key executives?

    Cobra Biologics's key executives are Daniel Smith, Lee Warren and Mike Austin.

  • How many employees does Cobra Biologics have?

    Cobra Biologics has 229 employees.

  • Who are Cobra Biologics competitors?

    Competitors of Cobra Biologics include Fujifilm Diosynth Biotechnologies, TFS and Comac Medical.

  • Where is Cobra Biologics headquarters?

    Cobra Biologics headquarters is located at Science Park University of Keele, Keele.

  • Where are Cobra Biologics offices?

    Cobra Biologics has offices in Keele and Matfors.

  • How many offices does Cobra Biologics have?

    Cobra Biologics has 2 offices.